Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura

scientific article

Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1345/APH.1H331
P8608Fatcat IDrelease_7alvrq4thrfe7brpyedw4ludxi
P698PubMed publication ID17062831

P2093author name stringZale P Bernstein
Yijun Cheng
Walter S Schroeder
Melissa S Baxter
P2860cites workHigh-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.Q33338284
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhageQ33341446
Experiences with recombinant human factor VIIa in patients with thrombocytopeniaQ33359266
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatmentQ33366023
Mechanism of action of high-dose factor VIIa: points of agreement and disagreementQ45857659
How factor VIIa works in hemophiliaQ45863820
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task ForceQ45882922
Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopeniaQ47418195
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectthrombocytopeniaQ585285
P304page(s)2053-2058
P577publication date2006-10-24
P1433published inAnnals of PharmacotherapyQ4767858
P1476titleDiminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura
P478volume40

Reverse relations

cites work (P2860)
Q33412076In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor
Q33382014Understanding the therapeutic action of recombinant factor VIIa in platelet disorders

Search more.